
Keywords: فیبرومیالژیا; Cannabinoids; Endocannabinoid system; Autoimmune diseases; Immunosuppression; Tetrahydrocannabinol (THC); Type 1 Diabetes; Neuropathic pain; Fibromyalgia; Inflammatory bowel disease; Multiple sclerosis; Scleroderma; Rheumatoid arthritis;